HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells.

Abstract
TNF-related apoptosis-inducing ligand (TRAIL) can induce apoptosis in various transformed cell lines. Therefore, we investigated TRAIL sensitivity, TRAIL-induced nuclear factor-kappaB (NF-kappaB) activation, and expression of TRAIL in human colonic adenocarcinoma cell lines (HT-29, LS180, SK-CO-1). All four TRAIL receptors (TRAIL-R1 through TRAIL-R4) are expressed in these cell lines. TRAIL sensitivity was assessed by assay of cell viability. Cancer cell viabilities were 83 +/- 3.1% (HT-29), 90 +/- 4.3% (LS180), and 88 +/- 6.3% (SK-CO-1) at 24 hours after the addition of 100 ng/ml TRAIL, indicating that these cell lines were relatively resistant to TRAIL. Activation of NF-kappaB was variably influenced by TRAIL administration, with no consistent tendency among the cell lines, indicating that TRAIL-induced NF-kappaB activation might be cell-type dependent. In contrast, TRAIL was expressed in the human colonic adenocarcinoma cell lines by Western blotting and RT-PCR. Increased expression of TRAIL on tumor cells was observed by flow cytometry after cytokine stimulation (IFN-gamma, TNF-alpha) or the addition of chemotherapeutic agents (camptothecin, doxolubicin hydrochloride). TRAIL on HT-29 cells was functional and able to induce apoptosis in Jurkat cells. Jurkat cell viability was increased by the addition of TRAILR1-R4-Fc. In the presence of various cytokines or chemotherapeutic agents, functional TRAIL is expressed on the surface of tumor cells, and this expressed TRAIL might contribute to tumor immune privilege by inducing apoptosis of activated human lymphocytes.
AuthorsHidekazu Inoue, Katsuya Shiraki, Takenari Yamanaka, Shigeru Ohmori, Takahisa Sakai, Masatoshi Deguchi, Hiroshi Okano, Kazumoto Murata, Kazushi Sugimoto, Takeshi Nakano
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 82 Issue 9 Pg. 1111-9 (Sep 2002) ISSN: 0023-6837 [Print] United States
PMID12218071 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apoptosis Regulatory Proteins
  • Interferon-alpha
  • Membrane Glycoproteins
  • NF-kappa B
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Receptors, Tumor Necrosis Factor
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFRSF10A protein, human
  • TNFRSF10B protein, human
  • TNFSF10 protein, human
  • Tumor Necrosis Factor-alpha
  • Doxorubicin
  • Interferon-gamma
  • Camptothecin
Topics
  • Adenocarcinoma (chemistry, pathology)
  • Apoptosis
  • Apoptosis Regulatory Proteins
  • Camptothecin (pharmacology)
  • Colonic Neoplasms (chemistry, pathology)
  • Doxorubicin (pharmacology)
  • HT29 Cells
  • Humans
  • Interferon-alpha (pharmacology)
  • Interferon-gamma (pharmacology)
  • Jurkat Cells
  • Membrane Glycoproteins (analysis, physiology)
  • NF-kappa B (metabolism)
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Receptors, Tumor Necrosis Factor (analysis)
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Necrosis Factor-alpha (analysis, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: